Literature DB >> 6807333

Tocainide protein binding in normal volunteers and trauma patients.

A T Elvin, J E Axelson, D Lalka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6807333      PMCID： PMC1402026          DOI： 10.1111/j.1365-2125.1982.tb01882.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.

Authors:  K M Piafsky; O Borgå
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

2.  Plasma binding and the affinity of propranolol for a beta receptor in man.

Authors:  D G McDevitt; M Frisk-Holmberg; J W Hollifield; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1976-08       Impact factor: 6.875

3.  Serum concentrations of free diphenylhydantoin and their relationship to clinical intoxication.

Authors:  H E Booker; B Darcey
Journal:  Epilepsia       Date:  1973-06       Impact factor: 5.864

Review 4.  Disease-induced changes in the plasma binding of basic drugs.

Authors:  K M Piafsky
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

5.  Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction.

Authors:  P A Routledge; W W Stargel; G S Wagner; D G Shand
Journal:  Ann Intern Med       Date:  1980-11       Impact factor: 25.391

6.  Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphate.

Authors:  O Borgå; K M Piafsky; O G Nilsen
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

7.  Kinetics of the oral antiarrhythmic lidocaine congener, tocainide.

Authors:  D Lalka; M B Meyer; B R Duce; A T Elvin
Journal:  Clin Pharmacol Ther       Date:  1976-06       Impact factor: 6.875

8.  Factors influencing serum protein binding of lidocaine in humans.

Authors:  P J McNamara; R L Slaughter; J A Pieper; M G Wyman; D Lalka
Journal:  Anesth Analg       Date:  1981-06       Impact factor: 5.108

9.  Alpha1-acid glycoprotein concentration and protein binding in trauma.

Authors:  D J Edwards; D Lalka; F Cerra; R L Slaughter
Journal:  Clin Pharmacol Ther       Date:  1982-01       Impact factor: 6.875
  9 in total
  3 in total

Review 1.  Clinical pharmacokinetics of the newer antiarrhythmic agents.

Authors:  A M Gillis; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

Review 2.  Tocainide. A review of its pharmacological properties and therapeutic efficacy.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-08       Impact factor: 9.546

3.  Pharmacokinetics of tocainide in patients with severe renal failure.

Authors:  J Braun; F Sörgel; F Engelmaier; W P Gluth; U Gessler
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.